Q3 2022 Aquestive Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to the Aquestive Therapeutics Third Quarter 2022 Conference Call. (Operator Instructions) As a reminder, this call will be recorded.
I would now like to introduce your host for today's conference call, Bennett Watson of Westwicke Investor Relations. You may begin.
Thank you, operator. Good morning, and welcome to today's call. On today's call, I am joined by Dan Barber, Chief Executive Officer; and Ernie Toth, Chief Financial Officer, who are going to provide an overview of recent business developments and performance for the third quarter of 2022, followed by a Q&A session. During the Q&A session, the team will be joined by Dr. Steve Wargacki, Vice President of R&D; Ken Truitt, Chief Medical Officer; and Ken Marshall, Chief Commercial Officer.
As a reminder, the company's remarks today correspond to the earnings release that was issued after market close yesterday. In addition, a recording of today's call will be made available on Aquestive's website
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
